Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Understand which index funds fit a retirement strategy in 2024, including cost considerations and diversification benefits.
23,806 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Two very different players dominate the modern financial scene: Ally Financial builds on auto lending with a growing ...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
Governments are treating chipmaking as strategic. This article explains why intel's national security role matters fo...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
A bold claim about a $22.7 trillion enterprise AI opportunity could reshape portfolios. This piece breaks down the th...
A prominent Canadian investment firm has disclosed a new stake in Boyd Group Services, highlighting growing interest ...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
A broader AI software sell-off created a rare opportunity for long-term investors. Here are three blue-chip options t...
In late June 2026, XRP and XLM are both testing breakout attempts after weeks of consolidation. Neither has confirmed...
Apple’s latest product lineup signals more than new gadgets—it signals a large-scale AI strategy. This article breaks...
May could mark a turning point for investors eyeing the clean energy revival. This article breaks down two nuclear en...